Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

James Stevenson; Gregory J. Riely; Douglas E. Wood; Dara L. Aisner; Andrea L. Axtell; Jessica R. Bauman; Ankit Bharat; Joe Y. Chang; Aakash Desai; Thomas J. Dilling; Jonathan Dowell; Gregory A. Durm; Scott Gettinger; Travis E. Grotz; Matthew A. Gubens; Aditya Juloori; Rudy P. Lackner; Michael Lanuti; Benjamin Levy; Jules Lin; Billy W. Loo; Christine M. Lovly; Fabien Maldonado; Daniel Morgensztern; Trey C. Mullikin; Thomas Ng; Dawn Owen; Dwight H. Owen; Tejas Patil; Patricio M. Polanco; Jonathan Riess; Ana Lucia Ruano Mendez; Theresa A. Shapiro; Aditi P. Singh; Alda Tam; Tawee Tanvetyanon; Jane Yanagawa; Edwin Yau; Karen Yun; Kristina Gregory; Lisa Hang

doi:10.6004/jnccn.2026.0038

Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

James Stevenson
, Gregory J. Riely
, Douglas E. Wood
, Dara L. Aisner
, Andrea L. Axtell
, Jessica R. Bauman
, Ankit Bharat
, Joe Y. Chang
, Aakash Desai
, Thomas J. Dilling
, Jonathan Dowell
, Gregory A. Durm
, Scott Gettinger
, Travis E. Grotz
, Matthew A. Gubens
, Aditya Juloori
, Rudy P. Lackner
, Michael Lanuti
, Benjamin Levy
, Jules Lin

Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Tejas Patil, Patricio M. Polanco, Jonathan Riess, Ana Lucia Ruano Mendez, Theresa A. Shapiro, Aditi P. Singh, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Edwin Yau, Karen Yun, Kristina Gregory, Lisa Hang

Research output: Contribution to journal › Article › peer-review

Abstract

Mesothelioma is a rare cancer that originates from the mesothelial surfaces of certain sites within the body. Pleural mesothelioma is the most common type and represents approximately 85% of mesotheliomas. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for evaluation and treatment in patients with pleural mesothelioma. The NCCN Guidelines will continue to be updated annually based on available clinical evidence and panel consensus.

Original language	English (US)
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	24
Issue number	8
DOIs	https://doi.org/10.6004/jnccn.2026.0038
State	Published - Aug 1 2026
Externally published	Yes

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2026.0038

Cite this

Stevenson, J., Riely, G. J., Wood, D. E., Aisner, D. L., Axtell, A. L., Bauman, J. R., Bharat, A., Chang, J. Y., Desai, A., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Juloori, A., Lackner, R. P., Lanuti, M., Levy, B., ... Hang, L. (2026). Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 24(8). https://doi.org/10.6004/jnccn.2026.0038

Stevenson, J, Riely, GJ, Wood, DE, Aisner, DL, Axtell, AL, Bauman, JR, Bharat, A, Chang, JY, Desai, A, Dilling, TJ, Dowell, J, Durm, GA, Gettinger, S, Grotz, TE, Gubens, MA, Juloori, A, Lackner, RP, Lanuti, M, Levy, B, Lin, J, Loo, BW, Lovly, CM, Maldonado, F, Morgensztern, D, Mullikin, TC, Ng, T, Owen, D, Owen, DH, Patil, T, Polanco, PM, Riess, J, Ruano Mendez, AL, Shapiro, TA, Singh, AP, Tam, A, Tanvetyanon, T, Yanagawa, J, Yau, E, Yun, K, Gregory, K & Hang, L 2026, 'Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 24, no. 8. https://doi.org/10.6004/jnccn.2026.0038

@article{dea88a3484ad4a0399f565e7709819cd,

title = "Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology",

abstract = "Mesothelioma is a rare cancer that originates from the mesothelial surfaces of certain sites within the body. Pleural mesothelioma is the most common type and represents approximately 85\% of mesotheliomas. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for evaluation and treatment in patients with pleural mesothelioma. The NCCN Guidelines will continue to be updated annually based on available clinical evidence and panel consensus.",

author = "James Stevenson and Riely, \{Gregory J.\} and Wood, \{Douglas E.\} and Aisner, \{Dara L.\} and Axtell, \{Andrea L.\} and Bauman, \{Jessica R.\} and Ankit Bharat and Chang, \{Joe Y.\} and Aakash Desai and Dilling, \{Thomas J.\} and Jonathan Dowell and Durm, \{Gregory A.\} and Scott Gettinger and Grotz, \{Travis E.\} and Gubens, \{Matthew A.\} and Aditya Juloori and Lackner, \{Rudy P.\} and Michael Lanuti and Benjamin Levy and Jules Lin and Loo, \{Billy W.\} and Lovly, \{Christine M.\} and Fabien Maldonado and Daniel Morgensztern and Mullikin, \{Trey C.\} and Thomas Ng and Dawn Owen and Owen, \{Dwight H.\} and Tejas Patil and Polanco, \{Patricio M.\} and Jonathan Riess and \{Ruano Mendez\}, \{Ana Lucia\} and Shapiro, \{Theresa A.\} and Singh, \{Aditi P.\} and Alda Tam and Tawee Tanvetyanon and Jane Yanagawa and Edwin Yau and Karen Yun and Kristina Gregory and Lisa Hang",

year = "2026",

month = aug,

day = "1",

doi = "10.6004/jnccn.2026.0038",

language = "English (US)",

volume = "24",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Harborside Press",

number = "8",

}

TY - JOUR

T1 - Mesothelioma

T2 - Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

AU - Stevenson, James

AU - Riely, Gregory J.

AU - Wood, Douglas E.

AU - Aisner, Dara L.

AU - Axtell, Andrea L.

AU - Bauman, Jessica R.

AU - Bharat, Ankit

AU - Chang, Joe Y.

AU - Desai, Aakash

AU - Dilling, Thomas J.

AU - Dowell, Jonathan

AU - Durm, Gregory A.

AU - Gettinger, Scott

AU - Grotz, Travis E.

AU - Gubens, Matthew A.

AU - Juloori, Aditya

AU - Lackner, Rudy P.

AU - Lanuti, Michael

AU - Levy, Benjamin

AU - Lin, Jules

AU - Loo, Billy W.

AU - Lovly, Christine M.

AU - Maldonado, Fabien

AU - Morgensztern, Daniel

AU - Mullikin, Trey C.

AU - Ng, Thomas

AU - Owen, Dawn

AU - Owen, Dwight H.

AU - Patil, Tejas

AU - Polanco, Patricio M.

AU - Riess, Jonathan

AU - Ruano Mendez, Ana Lucia

AU - Shapiro, Theresa A.

AU - Singh, Aditi P.

AU - Tam, Alda

AU - Tanvetyanon, Tawee

AU - Yanagawa, Jane

AU - Yau, Edwin

AU - Yun, Karen

AU - Gregory, Kristina

AU - Hang, Lisa

PY - 2026/8/1

Y1 - 2026/8/1

N2 - Mesothelioma is a rare cancer that originates from the mesothelial surfaces of certain sites within the body. Pleural mesothelioma is the most common type and represents approximately 85% of mesotheliomas. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for evaluation and treatment in patients with pleural mesothelioma. The NCCN Guidelines will continue to be updated annually based on available clinical evidence and panel consensus.

AB - Mesothelioma is a rare cancer that originates from the mesothelial surfaces of certain sites within the body. Pleural mesothelioma is the most common type and represents approximately 85% of mesotheliomas. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for evaluation and treatment in patients with pleural mesothelioma. The NCCN Guidelines will continue to be updated annually based on available clinical evidence and panel consensus.

UR - https://www.scopus.com/pages/publications/105047644622

UR - https://www.scopus.com/pages/publications/105047644622#tab=citedBy

U2 - 10.6004/jnccn.2026.0038

DO - 10.6004/jnccn.2026.0038

M3 - Article

C2 - 42607715

AN - SCOPUS:105047644622

SN - 1540-1405

VL - 24

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 8

ER -

Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this